Send Message

Veterinary Injectable Drugs Ca-Vitaplus Injection Use for Calcium Magnesium Vitamin B Deficiency

1000
MOQ
USD 1-3/bottle
Price
Veterinary Injectable Drugs Ca-Vitaplus Injection Use for Calcium Magnesium Vitamin B Deficiency
Features Gallery Product Description Request A Quote
Features
Specifications
Route Of Administration: Injection
Product Name: Veterinary Injectable Drugs
Packaging: Carton
Manufacturer: Chuangxin
Form: Liquid
Type: Injectable
Indication: Veterinary
Basic Infomation
Place of Origin: HENAN CHINA
Brand Name: CXBT & ShowVet
Certification: GMP OEM ISO9001 Veterinary Drug Production License
Model Number: Veterinary Injectable Drugs
Payment & Shipping Terms
Packaging Details: Carton
Delivery Time: 15 working days after payment
Payment Terms: L/C, D/A, D/P, T/T, Western Union, MoneyGram
Supply Ability: 50000bottle/Week
Product Description

Veterinary Injectable Drugs Ca-Vitaplus Injection

Composition

Each ml contains:

Calcium Gluconate..........208.3mg

Magnesium Hypophosphite…..…53.3mg

Magnesium Chloride...….....20mg

Boric Acide.............…..43.3mg

Vitamin B1 (Thiamine Hydrochloride)…....…....1mg

Riboflavin 5'-Phosphate Sodium (Vitamin B2)…...0.7mg

Vitamin B12 (Cyanocobalamin)…..0.03mg

Nicotinamide.............….2mg

Indications

For control of calcium-magnesium-vitamin B group deficiencies in cattle, horses, sheep and goats.

Administration and Dosage

For slow intravenous injection:

Cattle: 45-60 ml per 50 kg body weight

Horses, sheep and goats: 35 ml per 50 kg body weight

After a minimum of 6 hours after treatment, a second treatment may be administered. Additional treatments every 24 hours can be administered if it is clear that on-going symptoms are due to hypocalcaemia.

Contraindication

Do not use in cases of: hypercalcaemia and hypermagnesaemia; idiopathic hypocalcaemia in foals; calcinosis in cattle and small ruminants; septicaemia in the course of acute mastitis in cattle; chronic renal insufficiency or cases of circulatory or cardiac disorders.

Do not use following application of high doses of vitamin D3 preparations.

Do not use concomitantly or immediately following application of inorganic phosphorous solutions. Do not use in cases of known hypersensitivity to the active substances.

Adverse Reaction

Transient hypercalcaemia with the following symptoms may occur in very rare cases: initial bradycardia; restlessness, muscle tremor, salivation; increase in respiratory rate.

Withdrawal Time

None

Storage and Expired Time

Tightly sealed and store in a dark place below 30ºC.

2 years

Packing

100ml

Recommended Products
Get in touch with us
Contact Person : Dax.Yang
Tel : 13653816731
Characters Remaining(20/3000)